Franco A A, Mundy L M, Trucksis M, Wu S, Kaper J B, Sears C L
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Infect Immun. 1997 Mar;65(3):1007-13. doi: 10.1128/IAI.65.3.1007-1013.1997.
Strains of Bacteroides fragilis that produce a ca. 20-kDa heat-labile protein toxin (termed B. fragilis toxin [BFT]) have been associated with diarrheal disease of animals and humans. BFT alters the morphology of intestinal epithelial cells both in vitro and in vivo and stimulates secretion in ligated intestinal segments of rats, rabbits, and lambs. Previous genetic and biochemical data indicated that BFT was a metalloprotease which hydrolyzed G (monomeric) actin, gelatin, and azocoll in vitro. In this paper, the cloning and sequencing of the entire B. fragilis toxin gene (bft) from enterotoxigenic B. fragilis (ETBF) 86-5443-2-2 is reported. The bft gene from this ETBF strain consists of one open reading frame of 1,191 nucleotides encoding a predicted 397-residue holotoxin with a calculated molecular weight of 44,493. Comparison of the predicted BFT protein sequence with the N-terminal amino acid sequence of purified BFT indicates that BFT is most probably synthesized by ETBF strains as a preproprotein. These data predict that BFT is processed to yield a biologically active toxin of 186 residues with a molecular mass of 20.7 kDa which is secreted into the culture supernatant. Analysis of the holotoxin sequence predicts a 20-residue amphipathic region at the carboxy terminus of BFT. Thus, in addition to the metalloprotease activity of BFT, the prediction of an amphipathic domain suggests that oligomerization of BFT may permit membrane insertion of the toxin with creation of a transmembrane pore. Comparison of the sequences available for the bft genes from ETBF 86-5443-2-2 and VPI 13784 revealed two regions of reduced homology. Hybridization of oligonucleotide probes specific for each bft to toxigenic B.fragilis strains revealed that 51 and 49% of toxigenic strains contained the 86-5433-2-2 and VPI 13784 bft genes, respectively. No toxigenic strain hybridized with both probes. We propose that these two subtypes of bft be termed bft-1 (VPI 13784) and bft-2 (86-5433-2-2).
产生一种约20 kDa热不稳定蛋白毒素(称为脆弱拟杆菌毒素[BFT])的脆弱拟杆菌菌株与动物和人类的腹泻病有关。BFT在体外和体内均可改变肠上皮细胞的形态,并刺激大鼠、兔子和羔羊结扎肠段的分泌。先前的遗传和生化数据表明,BFT是一种金属蛋白酶,在体外可水解G(单体)肌动蛋白、明胶和偶氮胶体。本文报道了产肠毒素脆弱拟杆菌(ETBF)86 - 5443 - 2 - 2中整个脆弱拟杆菌毒素基因(bft)的克隆和测序。该ETBF菌株的bft基因由一个1191个核苷酸的开放阅读框组成,编码一个预测的397个残基的全毒素,计算分子量为44493。将预测的BFT蛋白序列与纯化BFT的N端氨基酸序列进行比较表明,BFT很可能由ETBF菌株作为前原蛋白合成。这些数据预测,BFT经过加工后产生一种具有生物活性的毒素,由186个残基组成,分子量为20.7 kDa,分泌到培养上清液中。对全毒素序列的分析预测在BFT的羧基末端有一个20个残基的两亲区域。因此,除了BFT的金属蛋白酶活性外,两亲结构域的预测表明BFT的寡聚化可能允许毒素插入膜并形成跨膜孔。对ETBF 86 - 5443 - 2 - 2和VPI 13784的bft基因可用序列进行比较,发现有两个同源性降低的区域。用针对每个bft的寡核苷酸探针与产毒素脆弱拟杆菌菌株杂交,结果显示分别有51%和49%的产毒素菌株含有86 - 5433 - 2 - 2和VPI 13784的bft基因。没有产毒素菌株与两种探针都杂交。我们建议将这两种bft亚型分别称为bft - 1(VPI 13784)和bft - 2(86 - 5433 - 2 - 2)。